Q2 and Q3Given that the 2nd quarter financials were released on Friday Jan 29th this year it stands to reason that the 3rd quarter results will be out on the last business day of the this month. No compelling reason to put this out early, on time is good enough. This will give shareholders something to sink their teeth into next weekend and decide if TEI is indeed turning the corner on the way to profitability.
Since the last quarter there have been 2 contract announcements and the settlement of one legal matter. If TEI can repeat this performance during the next quarter it will be very encouraging.
Unfortunatly large GEM sales were limited to one order during the last quarter and rather a small one at that. As we are not made aware of smaller orders there is an expectation that this type of sale is made regularily and doesn't merit disclosure. Shareholders could/should expect to see more large GEM sales shortly as the 20 odd trials in North America mentioned at the AGM get some traction and follow up orders. NHS sponsorship may also yield some further positive results soon.
Until next weekend.